Helsinki heart study

Author: nzkh

August undefined, 2024

WebHelsinki Heart Study Last reviewed 01/2024 double-blind, placebo-controlled trial - included 4,081 men aged 40-55 years who were free of CHD at the start of the study WebMay 27, 1998 · Frick MH, Elo O, Haapa K. et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. N Engl J Med. 1987;317:1237-1245. Google Scholar

The Helsinki Heart Study: an 8.5‐year safety and mortality follow‐up

WebNov 23, 2005 · Frick MH, Elo O, Haapa K. et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia: safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med. 1987;317:1237-12453313041Google Scholar Crossref WebI work as a coordinator of an international multicenter observational study named Epitranscriptomics of ischemic heart disease, IHD-EPITRAN, at the University of Helsinki, Faculty of Medicine, Department of Pharmacology as a PhD student. With special focus on ischemic heart disease, my principal scientific interests center on deepening and … scottish service design standards

The Helsinki Heart Study: basic design and …

WebSep 15, 2024 · This interview with Markus Reymann, Director of TBA21–Academy and its physical venue Ocean Space in Venice, took place in June 2024. It is part of a series of interviews that artist Jana Winderen and Executive Director and curator Paula Toppila are making as part of the research for Jana’s IHME Helsinki Commission 2024, now … WebApr 10, 2024 · Background. Donor-derived cell-free DNA (dd-cfDNA) testing is an emerging screening modality for noninvasive detection of acute rejection (AR). This study compared the testing accuracy for AR of two commercially available dd-cfDNA and gene-expression profiling (GEP) testing in heart transplant (HTx) recipients. WebBACKGROUND. We studied the joint effect of baseline triglyceride and lipoprotein cholesterol levels on the incidence of cardiac end points in the trial group (n = 4,081) of the Helsinki Heart Study, a 5-year randomized coronary primary prevention trial among dyslipidemic middle-aged men. preschool moving up ceremony

Helsinki Heart Study - General Practice notebook

Primary Prevention of Acute Coronary Events With Lovastatin in …

WebHelsinki Heart Study Last reviewed 01/2024 double-blind, placebo-controlled trial - included 4,081 men aged 40-55 years who were free of CHD at the start of the study WebAug 18, 2015 · The Helsinki Businessmen Study (HBS) is a clinico-epidemiological longitudinal study started in 1964. It also included a 5-year randomized, controlled … pre school musical disneyWebResearch design and methods: Of the 4081 men participating in the Helsinki Heart Study, a coronary primary prevention trial with gemfibrozil in middle-aged men with high non-high-density lipoprotein (HDL) cholesterol (greater than 5.2 … scottish sheepdog society

"WebOct 1, 1995 · We tested this hypothesis in 2702 dyslipidemic middle-aged men without renal disease participating in the Helsinki Heart Study, a coronary primary prevention trial. The decline in renal function was estimated from linear regression slopes based on reciprocals of 10 serum creatinine determinations over the study period. " - Helsinki heart study

Helsinki heart study

WebJul 18, 2007 · In the Helsinki Heart Study, gemfibrozil reduced the incidence of CHD events in middle-aged men by 71% if the fasting triglyceride level was greater than 200 mg/dL. 16 Trials currently under way, such as the AIM-HIGH trial funded by the National Heart, Lung, and Blood Institute, 19 will further evaluate the role of combination therapy in ... WebMar 17, 2024 · The primary end point occurred in 1344 patients (9.8%) in the evolocumab group and in 1563 patients (11.3%) in the placebo group (hazard ratio, 0.85; 95% CI, …

Did you know?

WebJoint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Circulation. 1992 Jan;85(1):37-45.doi: 10.1161/01.cir.85.1.37. Authors V Manninen 1 , L Tenkanen, P Koskinen, J K Huttunen, M Mänttäri, O P Heinonen, M H Frick WebNov 12, 1987 · Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. N Engl J Med. 1987 Nov 12;317(20):1237-45.doi: …

WebThe Helsinki Heart Study: an 8.5-year safety and mortality follow-up. J Intern Med. 1994 Jan; 235 (1):31–39. [Google Scholar] LEPESCHKIN E, SURAWICZ B. The measurement of the Q-T interval of the electrocardiogram. Circulation. 1952 Sep; 6 (3):378–388. [Google Scholar] Bland JM, Altman DG. Statistical methods for assessing agreement between ... WebHelsinki Heart Study (HHS, also known by its Finnish name; Sepelvaltimotaudin ehkäisyprojekti, SEP) was a randomized, double-blind, placebo-controlled trial testing whether the cholesterol lowering drug Gemfibrozil could reduce the risk of coronary heart disease among Finnish men. More than 4000 asymptomatic middle-aged men (40 to 55 …

WebNov 14, 2005 · The Helsinki Heart Study tested long-term fibrate (gemfibrozil) use in men with hypercholesterolaemia without previous coronary disease. Fibrates lowered … WebMar 16, 2010 · In the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Lipid trial, published on-line in the New England Journal of Medicine, (1) the group with atherogenic dyslipidemia had 70 percent...

WebJul 1, 1992 · Of the 4081 men participating in the Helsinki Heart Study, a coronary primary prevention trial with gemfibrozil in middle-aged men with high non-high-density lipoprotein (HDL) cholesterol (> 5.2 mM; 200 mg/dL), 135 had NIDDM at entry. The incidence of definite myocardial infarction and cardiac death and changes in serum and lipoprotein lipids ...

WebJan 1, 1994 · DOI: 10.1111/j.1365-2796.1994.tb01029.x Corpus ID: 20320242; The Helsinki Heart Study: an 8.5‐year safety and mortality follow‐up @article{Huttunen1994TheHH, … scottish shellfish marketing group ltdWebThe Helsinki Heart Study (10-13) was a controlled primary preventiontrial to test the hypothesisthat lowering the concentrationsof plasma low density lipoprotein (LDL) and very low density lipoprotein (VLDL) and raising that of high density lipoprotein (HDL) protects people against developing heart disease. This overwiew describes the central ... scottish shale oil museumWebThe Helsinki Heart Study (HHS) is a randomized double-blinded trial that assessed the primary cardiovascular preventive effect of elevation in HDL and decrease in non-HDL cholesterol with gemfibrozil . Study Description Publications scottish shelter for hikersWebThe Helsinki Heart Study was launched to investigate the effect of this agent on the incidence of coronary heart disease in a randomized, double-blind, five-year trial in … CARDIOVASCULAR disease remains the chief cause of death in the United Stat… scottish settlers in canadaWebHelsinki Heart Study (HHS, also known by its Finnish name; Sepelvaltimotaudin ehkäisyprojekti, SEP) was a randomized, double-blind, placebo-controlled trial testing … preschool murals for wallsWebApr 13, 2024 · This study was conducted to identify ischemic heart disease-related factors and vulnerable groups in Korean middle-aged and older women using data from the Korea National Health and Nutrition Examination Survey (KNHANES). Among the 24,229 people who participated in the 2024–2024 survey, 7249 middle-aged women aged 40 and over … scottish shetland sweaters scottish settlement in north carolina